TAFINLAR dabrafenib (as mesilate)10 mg dispersible tablet bottle (397093)

ARTG ID 397093

ARTG Name

TAFINLAR dabrafenib (as mesilate)10 mg dispersible tablet bottle

Product name

TAFINLAR dabrafenib (as mesilate) 10 mg dispersible tablet bottle

ARTG Date

6 December 2023

Registration Type

Medicine

Therapeutic good type

Medicine

Ingredients

dabrafenib mesilate

Licence category

RE

Licence status

A

Summary

Product information

Consumer medicine information

Related information

TAFINLAR dabrafenib (as mesilate) 10 mg dispersible tablet bottle , Novartis Pharmaceuticals Australia Pty Ltd , CON-1185

29 November 2023

Section 14 consent

Consent to while noncompliant with standards.
TAFINLAR dabrafenib (as mesilate)10 mg dispersible tablet bottle (2023-24)

2023-24

Annual charge exemption

Exempt from annual charge in 2023-24 due to Novartis Pharmaceuticals Australia Pty Ltd declaring $0 turnover in that period.